-
1
المصدر: The Journal of the American Dental Association. 153:1096-1103
مصطلحات موضوعية: medicine.medical_specialty, Orofacial pain, business.industry, Hearing loss, MEDLINE, Evidence based review, Scientific evidence, stomatognathic diseases, Otorhinolaryngology, medicine, medicine.symptom, Intensive care medicine, business, General Dentistry, Practical implications, Tinnitus
الوصف: Background The aim of this article is to discuss the scientific evidence available on the the pathophysiology and management of otologic complaints in patients with temporomandibular disorders (TMDs). Types of Studies Reviewed The authors conducted an electronic search in MEDLINE, Web of Science and ScienceDirect and retrieved all the relevant peer-reviewed journal articles available in English on the topic. No time restriction was applied. Results No consensus exists on the management of otologic symptoms in patients with concomitant TMD. The scientific evidence suggests that conservative or reversible TMD therapy might provide relief. However, this evidence is scarce and low, thus further studies with larger sample sizes and better designed methodological frameworks are needed. Until such evidence is available, dentists and orofacial pain specialists should treat TMD patients using current guidelines and refer those with otologic symptoms to an otolaryngologist. Practical Implications Given the wide range of potential pathophysiologies and treatments for each otologic symptom described in the TMD patient, close collaboration with otolaryngologists is essential to achieve the best patient care.
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::34f16350e50615ca5870d6ea4efb7923Test
https://doi.org/10.1016/j.adaj.2021.07.029Test -
2
المصدر: Revista Colombiana de Psiquiatría. 51:326-329
مصطلحات موضوعية: Paliperidone Palmitate, medicine.medical_specialty, Risperidone, Delusional disorder, Aggression, media_common.quotation_subject, Jealousy, Context (language use), medicine.disease, 030227 psychiatry, Scientific evidence, 03 medical and health sciences, Psychiatry and Mental health, 0302 clinical medicine, medicine, General Earth and Planetary Sciences, medicine.symptom, Psychology, Psychiatry, Psychiatric ward, 030217 neurology & neurosurgery, General Environmental Science, media_common, medicine.drug
الوصف: Introduction Although delusional jealousy accounts for merely 10% of delusional disorders, it is associated to risk of serious violence and suicide. With this clinical case, we intend to explore the difficulties in the pharmacological approach of delusional jealousy disorder and to summarise the most recent findings in the treatment of this condition. Methods Case report. Case presentation A 76-year-old man involuntarily admitted to a psychiatric ward due to threats of physical aggression to his wife in the context of irreducible ideas of her infidelity. Initially, we observed an improvement of symptomatology with risperidone and its long-acting injectable formulation, but the emergence of hypotensive side effects required the off-label use of paliperidone palmitate 50 mg/ml. Conclusions Few studies, mainly case reports, look at the specific treatment of delusional jealousy. Given the negative consequences for patients and for their spouses, better scientific evidence to treat this condition is needed.
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3a0fb75782a5486db0d21cc56d547792Test
https://doi.org/10.1016/j.rcp.2020.12.004Test -
3
المؤلفون: Carsten Hagenbeck, Philip Hepp, Janine Zöllkau, Tanja Fehm, Nora K. Schaal
المصدر: Archives of Gynecology and Obstetrics
مصطلحات موضوعية: medicine.medical_specialty, COVID-19 Vaccines, Breastfeeding, Disease, Pregnant, Anxiety, Maternal-Fetal Medicine, Scientific evidence, Pregnancy, Pandemic, medicine, Humans, ddc:610, Pandemics, SARS-CoV-2, business.industry, Vaccination, COVID-19, Obstetrics and Gynecology, Fear, General Medicine, medicine.disease, Breast Feeding, Cross-Sectional Studies, Harm, Family medicine, Female, Pregnant Women, medicine.symptom, business
الوصف: Purpose The COVID-19 vaccination is probably the most important source to fight the COVID-19 pandemic. However, recommendations and possibilities for vaccination for pregnant and breastfeeding women are inconsistent and dynamically changing. Methods An anonymous, online, cross-sectional survey was conducted among pregnant and breastfeeding women in Germany between 30th March and 19th April 2021 addressing COVID-19 vaccination attitudes including the underlying reasons for their decision. Additionally, anxiety regarding a SARS-CoV-2 infection and a symptomatic course of the infection were evaluated. Results In total, 2339 women (n = 1043 pregnant and n = 1296 breastfeeding) completed the survey. During pregnancy the majority (57.4%) are not in favour of receiving the vaccine, 28.8% are unsure and only 13.8% would get vaccinated at the time of the survey. In contrast, 47.2% would be in favour to receive the vaccine, if more scientific evidence on the safety of the vaccination during pregnancy would be available. Breastfeeding women show higher vaccination willingness (39.5% are in favour, 28.1% are unsure and 32.5% not in favour). The willingness to be vaccinated is significantly related to the women’s anxiety levels of getting infected and to develop disease symptoms. Main reasons for vaccination hesitancy are the women’s perception of limited vaccination-specific information, limited scientific evidence on vaccination safety and the fear to harm the fetus or infant. Conclusions The results provide important implications for obstetrical care during the pandemic as well as for official recommendations und information strategies regarding the COVID-19 vaccination.
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c7f0cd43b4bc730fd961475bbacd3cadTest
https://doi.org/10.1007/s00404-021-06297-zTest -
4
المصدر: World Journal of Clinical Cases
مصطلحات موضوعية: Psychiatry, Depression, business.industry, Psychological intervention, Review, General Medicine, Affect (psychology), Mental health, Scientific evidence, Religion, Distress, Spirituality, Medicine, Anxiety, medicine.symptom, business, Depression (differential diagnoses), Clinical psychology
الوصف: Research in the field of “Spirituality and Health” has been growing, with spirituality/religiousness (S/R) being consistently related to both physical and mental health. The objective of this article is to provide an updated review of the current scientific evidence on the relationship between S/R and mental health, highlighting the most important studies. As a secondary objective, the mechanisms that explain this relationship and the interventions that utilize this information in treating mental disorders will be discussed. The findings reveal a large body of evidence across numerous psychiatric disorders. Although solid evidence is now available for depression, suicidality, and substance use, other diagnosis, such as post-traumatic stress disorder, psychosis, and anxiety, have also shown promising results. The effects of S/R on mental health are likely bidirectional, and the manner in which religious beliefs are used to cope with distress (i.e. negative and positive), may affect mental health outcomes. Despite these findings, the mechanisms that explain these associations and the role of S/R interventions need further study. Concerning clinical practice, mental health providers should ask patients about S/R that are important in their lives to provide holistic and patient-centered care.
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::47bb33b644d1f6e292dea69d4282e53bTest
https://doi.org/10.12998/wjcc.v9.i26.7620Test -
5
المؤلفون: Huma Naqvi, Soo Yeon Kim, John M. Baratta, Jason H. Maley, Talya K. Fleming, Eric Herman, William Niehaus, Jonathan Whiteson, Alba Azola, Joseph E. Herrera, Julie K. Silver, Monica Verduzco Gutierrez, Benjamin A. Abramoff, Sarah Sampsel
المصدر: Pm & R
PM Rمصطلحات موضوعية: medicine.medical_specialty, Departments, Consensus, Psychological intervention, MEDLINE, Physical Therapy, Sports Therapy and Rehabilitation, Context (language use), Scientific evidence, Post-Acute COVID-19 Syndrome, Multidisciplinary approach, medicine, Animals, Humans, Horses, Intensive care medicine, Fatigue, Depression (differential diagnoses), SARS-CoV-2, business.industry, Rehabilitation, COVID-19, Health equity, Neurology, Disease Progression, Anxiety, Neurology (clinical), medicine.symptom, business, Clinical Guidance
الوصف: Large numbers of individuals who have been infected with SARS‐CoV‐2, the virus responsible for COVID‐19, continue to experience a constellation of symptoms long past the time that they have recovered from the acute stages of their illness. Often referred to as “long COVID,” these symptoms, which can include fatigue, shortness of breath, palpitations, cognitive dysfunction (“brain fog”), sleep disorders, fevers, gastrointestinal symptoms, anxiety, depression, and others, can persist for months and can range from mild to incapacitating. Although still being defined, these effects can be collectively referred to as postacute sequelae of SARS‐CoV‐2 infection (PASC).1 The magnitude of this problem is not yet known, but given the millions of individuals worldwide who have had, or will have, COVID‐19, the societal impacts are likely to be profound and long lasting.2, 3, 4, 5 It is widely acknowledged that systematic study is needed to develop an evidence‐based approach for caring for patients with PASC. At present, there is a dearth of rigorous scientific evidence regarding effective assessment and treatment of PASC that prevents the creation of evidence‐based clinical guidelines. However, the U.S. health system is currently seeing an increase in the number of patients presenting with PASC, and there is an urgent need for clinical guidance in treating these patients. The goal of this, and future statements, is to provide practical guidance to clinicians in the assessment and treatment of patients presenting with PASC. This Consensus Guidance Statement on fatigue is the first of a series focused on the most prominent PASC symptoms. PASC consensus guidance statement methods The American Academy of Physical Medicine and Rehabilitation (AAPM&R) Multi‐Disciplinary PASC Collaborative (“PASC Collaborative”) was created, in part, to develop expert recommendations and guidance from established PASC centers with extensive experience in managing patients with PASC. The PASC Collaborative is following an iterative, development approach to achieve consensus on assessment and treatment recommendations for a series of Consensus Guidance Statements focused on the most prominent PASC symptoms. These statements were developed by a diverse team of experts, with input from patient representatives with a history of PASC, and integrate current experience and expertise with available evidence to provide tools to clinicians treating patients. There is an intentional focus on health equity as disparities in care and outcomes are critically important to address. Beyond patient care, the hope is that a broadened understanding of current patient care practices will help identify areas of future research. A full description of the methodology is also published in this issue.6 We acknowledge that the definition of PASC is evolving, and there are various factors that contribute to diagnosis. The PASC Collaborative sought input from patient representatives with a history of PASC and patient‐led research initiatives to inform recommendations. For example, previous literature has suggested that PASC be defined as the continuation of symptoms beyond 3 or 4 weeks from the onset of acute infection.7 Other definitions of PASC include symptoms lasting longer than 3 months.8 Based on feedback of patient representatives that earlier evaluation, diagnosis, and management can improve access to beneficial interventions, for the purpose of this Consensus Guidance Statement, we recommend expanded assessment if symptoms are not improving 1 month after acute symptom onset. These Consensus Guidance Statements are intended to reflect current practice in patient assessment, testing, and treatments. They should not preclude clinical judgment and must be applied in the context of the specific patient, with adjustments for patient preferences, comorbidities, and other factors.
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c9cf23a7cd50381f7d22a33c7373f911Test
https://doi.org/10.1002/pmrj.12684Test -
6
المؤلفون: Robert J. Adams, Nicole Lovato, Richard Reed, Alexander Sweetman, Andrew Vakulin, Leon Lack, Malcolm Battersby, Emer Van Ryswyk
المصدر: Medical Journal of Australia. 215:230-236
مصطلحات موضوعية: medicine.medical_specialty, Referral, medicine.medical_treatment, Comorbidity, Scientific evidence, Sleep Initiation and Maintenance Disorders, mental disorders, Insomnia, Humans, Medicine, Psychiatry, Depression (differential diagnoses), Cognitive Behavioral Therapy, Primary Health Care, Depression, business.industry, Australia, General Medicine, medicine.disease, Antidepressive Agents, nervous system diseases, Cognitive behavioral therapy, Mood, medicine.symptom, business, Management of depression
الوصف: Depression and insomnia commonly co-occur, resulting in greater morbidity for patients, and difficult diagnostic and treatment decisions for clinicians. When patients report symptoms of both depression and insomnia, it is common for medical practitioners to conceptualise the insomnia as a secondary symptom of depression. This implies that there is little purpose in treating insomnia directly, and that management of depression will improve both the depression and insomnia symptoms. In this review, we present an overview of research investigating the comorbidity and treatment approaches for patients presenting with depression and insomnia in primary care. Evidence shows that clinicians should avoid routinely conceptualising insomnia as a secondary symptom of depression. This is because insomnia symptoms: (i) often occur before mood decline and are independently associated with increased risk of future depression; (ii) commonly remain unchanged following depression treatment; and (iii) predict relapse of depression after treatment for depression only. Furthermore, compared with control, cognitive behaviour therapy for insomnia improves symptoms of both depression and insomnia. It is critical that primary care clinicians dedicate specific diagnostic and treatment attention to the management of both depression (eg, psychotherapy, antidepressants) and insomnia (eg, cognitive behaviour therapy for insomnia administered by trained therapists or psychologists through a mental health treatment plan referral, by online programs, or by a general practitioner or nurse) when they co-occur. These treatments may be offered concurrently or sequentially (eg, insomnia treatment followed by depression treatment, or vice versa), depending on presenting symptoms, history, lifestyle factors and other comorbidities.
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9085076f90b03d284f3583d37009840dTest
https://doi.org/10.5694/mja2.51200Test -
7
المؤلفون: Anne Lieutaud, Karine Grenier, Danis Bois
المصدر: Alternative and Complementary Therapies. 27:176-186
مصطلحات موضوعية: Psychotherapist, Mind–body problem, Flourishing, medicine.medical_treatment, media_common.quotation_subject, Self-esteem, Field survey, Scientific evidence, Complementary and alternative medicine, Psychoeducation, medicine, Anxiety, medicine.symptom, Psychology, media_common
الوصف: Introduction: Mind–body approaches are flourishing to answer the need for support in an increasingly demanding world. To provide scientific evidence of their effectiveness and contribute to the dis...
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::e87b9f294331461c4c0bb3dd8f94c3adTest
https://doi.org/10.1089/act.2021.29341.aliTest -
8
المؤلفون: Miguel Antonio Vargas García, Valeria Bustamante Arboleda, Catalina Valvuena Cuartas, Ana Ospina Ruiz
المصدر: Areté. 21:55-64
مصطلحات موضوعية: medicine.medical_specialty, Food intake, Rehabilitation, business.industry, medicine.medical_treatment, General Medicine, Dysphagia, Scientific evidence, Systematic review, Swallowing, Intervention (counseling), medicine, medicine.symptom, Intensive care medicine, Speech-Language Pathology, business
الوصف: La presente revisión se planteó con el fin de recopilar la evidencia existente sobre el abordaje rehabilitador de la disfagia en adultos mayores con enfermedades neurodegenerativas, con la intención de encontrar propuestas de tratamientos que influyan de manera positiva en la salud de los pacientes. Los métodos de búsqueda se implementaron bajo un proceso ordenado de revisión sistemática bajo el modelo Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA), a través de la cual se recolecta información de forma cronológica sobre la evidencia científica de un tema en particular. Para ello se usaron descriptores como: “Adulto; Neurodegenerativa; Disfagia; Rehabilitación”. En la revisión sistemática se incluyeron 21 artículos, entre estos se mencionaron estudios y revisiones sobre los tratamientos empleados en las enfermedades neurodegenerativas. En los hallazgos es evidente la intervención multidisciplinar, modificación del entorno, uso de fármacos como medio para mitigar síntomas principalmente motores, procedimientos quirúrgicos; además, maniobras deglutorias, compensatorias, rehabilitadoras, entre otras. Algunas alternativas requieren de la participación del Fonoaudiólogo/Logopeda debido a que en la mayoría de personas que padecen enfermedades neurodegenerativas se ve afectada la fase oral y/o faríngea de la deglución, desencadenando disfagia en diferentes grados de severidad y comprometiendo de forma directa la ingesta de alimentos debido al riesgo de aspiración, neumonía y/o muerte y a su vez, la calidad de vida. Esta revisión sistemática permite identificar la necesidad de realizar más propuestas terapéuticas, estudios que evidencien su eficacia y que, sobre todo, generen cambios significativos en quienes padecen las enfermedades descritas.
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2bb48ea524c7672d815c9e5b2cf05a95Test
https://doi.org/10.33881/1657-2513.art.21105Test -
9
المؤلفون: Paulo José Barbosa Gutierres Filho, Maria Elisa Caputo Ferreira, Clara Mockdece Neves, Fabiane Frota da Rocha Morgado, Ravine Carvalho Pessanha Coelho da Silva, Augusta Karla Silva Quintanilha, Vitor Alexandre Rabelo de Almeida, Juliana Fernandes Filgueiras Meireles
المصدر: Educação: Teoria e Prática. 31:1-24
مصطلحات موضوعية: Biopsychosocial model, education.field_of_study, Visual impairment, Population, Scopus, PsycINFO, Scientific evidence, medicine, medicine.symptom, Construct (philosophy), Psychology, education, Psychosocial, Clinical psychology
الوصف: A imagem corporal é um constructo amplamente estudado e pesquisas nessa área têm aumentado nos últimos anos, entretanto adolescentes com deficiência visual ainda carecem de investigação. Esta revisão sistemática tem por objetivo investigar trabalhos que buscam evidências científicas sobre aspectos da imagem corporal de adolescentes com deficiência visual. Realizou-se uma busca sistemática de artigos em quatro bases de dados, Scopus, PsycInfo, PubMed e Web of Science. O recrutamento dos estudos, sem restrição temporal, foi concluído em 8 de junho de 2019. Foram incluídos 32 artigos, os quais se classificaram em quatro categorias: (1) aspectos psicossociais do corpo, (2) conceito corporal, (3) atividade física/saúde (4) instrumentos de avaliação da imagem corporal e insatisfação corporal. A maioria dos estudos inseridos nesta revisão demonstraram, mediante evidências científicas, que há implicações negativas sobre a imagem corporal de adolescentes com deficiência visual, Alguns achados, contudo, baseiam-se nas limitações da deficiência, valorizando o déficit orgânico. Fazem-se necessários estudos que busquem uma abordagem biopsicossocial na formação da imagem corporal positiva nesta população.
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::8d420a8778e79da2704334f82abf2f40Test
https://doi.org/10.18675/1981-8106.v31.n.64.s15171Test -
10
المصدر: Allergologia et Immunopathologia. 49:17-20
مصطلحات موضوعية: Pulmonary and Respiratory Medicine, medicine.medical_specialty, Pediatrics, Constipation, business.industry, Immunology, food and beverages, Milk allergy, General Medicine, Hepatology, medicine.disease, Scientific evidence, Atopy, 03 medical and health sciences, 0302 clinical medicine, 030228 respiratory system, Elimination diet, Internal medicine, Immunology and Allergy, Medicine, Functional constipation, medicine.symptom, Family history, business, 030215 immunology
الوصف: Functional constipation (FC) is one of the most common disorders in childhood and has a neg-ative impact on the quality of life of children. Scientific evidence regarding a causal relation-ship between FC and cow’s milk allergy is controversial, as it is also reported by the latest European Society for Paediatric Gastroenterology, Hepatology and Nutrition-North American Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN–NASPGHAN) rec-ommendations. In the case of FC, routine allergometric tests are not recommended and the cows’ milk-free diet is only proposed in the case of laxative-resistant constipation and only following the advice of an expert. Instead, after a careful review of the literature and in view of the many clinical cases encountered in our clinical practice, we believe that it is useful to propose cows’ milk-free diet as first line for the treatment of FC at least in pre-school children and in children with a personal or family history of atopy or with a previous diagnosis of cow’s milk protein allergy.
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::8c45e64a6a0bf0ed99dee9d8d8ac6059Test
https://doi.org/10.15586/aei.v49i3.72Test